Improved vaccination strategies
for older adults

A collaborative effort by the ISOLDA consortium to lower morbidity and mortality due to viral diseases in adults aged 65 years or over.

Who are we?

Find out more about the ISOLDA consortium.

Our activities

Learn how ISOLDA aims at developing vaccines against viral diseases that are better tailored to older adults.

News and updates

Stay informed about the developments in the ISOLDA consortium.

Contact us

Reach out to us for more information.
The ISOLDA project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 848166.